Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
102
Frequently Asked Questions
What is Market Cap of Mersana Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Mersana Therapeutics Inc market cap is $38.23M.
What is the 52-week high for Mersana Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Mersana Therapeutics Inc 52 week high is $70.75 as of September 10, 2025.
What is the 52-week low for Mersana Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Mersana Therapeutics Inc 52 week low is $5.21 as of September 10, 2025.
What is Mersana Therapeutics Inc stock price today?
Mersana Therapeutics Inc stock price today is $7.35.
What was Mersana Therapeutics Inc stock price yesterday?
Mersana Therapeutics Inc stock price yesterday was $7.66.
What is the PE ratio of Mersana Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Mersana Therapeutics Inc’s P/E ratio is -0.51.
What is the Price-to-Book ratio of Mersana Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Mersana Therapeutics Inc P/B ratio is -0.7193.
What is the 50-day moving average of Mersana Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Mersana Therapeutics Inc 50-day moving average is $7.54.
How many employess does Mersana Therapeutics Inc has?